115744 ⎘
Transferases transferring phosphorus-containing groups (2.7); Phosphotransferases with an alcohol group as acceptor (2.7.1) Thymidine kinase (2.7.1.21)
MEDICINAL PREPARATION FOR COMBINED GENE-DIRECTED ENZYME PRODRUG THERAPY AND IMMUNOTHERAPY OF SOLID MALIGNANT TUMOURS (EMBODIMENTS)
#2GENE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES
#3STEM CELL BASED DELIVERY OF TUMOR-SPECIFIC RETROVIRAL VECTORS
#4COMPOSITIONS AND METHODS FOR IDENTIFICATION OF VHH ANTIBODIES THAT BIND A TARGET ANTIGEN
#5ZIKV-BASED GENE DELIVERY SYSTEM
#6SECRETED RNA THERAPEUTICS FOR NUCLEAR DELIVERY
#7ENGINEERING SUICIDE GENE APPROACHES TO IMPROVE CHEMOTHERAPEUTIC RESPONSE IN CANCER
#8CHICKEN-DERIVED RECOMBINANT FULL-LENGTH MONOCLONAL IGY ANTIBODY AGAINST HUMAN THYMIDINE KINASE 1 AND APPLICATIONS THEREOF
#9METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS
#10Transgenic Macrophages, Chimeric Antigen Receptors, and Associated Methods
#11METHODS FOR THE TEMPORAL REGULATION OF REPROGRAMMING FACTORS IN MAMMALIAN CELLS
#12ADENO-ASSOCIATED VIRAL (AAV) VECTORS FOR TISSUE-TARGETED EXPRESSION OF THERAPEUTIC GENES
#13RNA Trans-Splicing Molecule
#14COMPOSITIONS AND METHODS FOR TREATING CANCER
#15FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD
#16CELLS WITH SUSTAINED TRANSGENE EXPRESSION
#17BIG-IN: A VERSATILE PLATFORM FOR LOCUS-SCALE GENOME REWRITING AND VERIFICATION
#18IMMUNOENGINEERED PLURIPOTENT CELLS
#19METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS
#20RECOMBINANT VACCINIA VIRUS
#21Nanoparticle Modification of Human Adipose-Derived Mesenchymal Stem Cells for Treating Brain Cancer and Other Neurological Diseases
#22THYMIDINE KINASE GENE
#23Cyclin G1 inhibitors and related methods of treating cancer
#24Macrophage CAR (MOTO-CAR) In Immunotherapy
#25METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS
#26ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS
#27DNA, EXPRESSION VECTOR, TRANSCRIPT, CELL, PHARMACEUTICAL COMPOSITION, AND MEDICINE
#28CHIMERIC CYTOKINE RECEPTORS
#29Transgenic macrophages, chimeric antigen receptors, and associated methods
#30SERUM THYMIDINE KINASE 1 DETECTION KIT BASED ON AUTOMATIC CHEMILUMINESCENCE ANALYZER
#31Development of recombinant chicken IGY SCFV antibody raised against human thymidine kinase 1 expressed in prokaryotic cells and use thereof
#32THERAPEUTIC CONSTRUCTS FOR TREATING CANCER
#33GENE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES
#34Recombinant vaccinia virus and methods of use thereof
#35Thymidine kinase gene
#36Transcriptionally targeted and CpG-free plasmid for theranostic gene therapy
#37Transgene-Cytotoxic Combination Therapy
#38Engineering stem cells for cancer therapy
#39Nanoparticle modification of human adipose-derived mesenchymal stem cells for treating brain cancer and other neurological diseases
#40Transgenic macrophages, chimeric antigen receptors, and associated methods
#41Cyclin G1 inhibitors and related methods of treating cancer
#42IMMUNOENGINEERED PLURIPOTENT CELLS
#43Thymidine kinase diagnostic assay for gene therapy applications
#44METHODS OF CYTOTOXIC GENE THERAPY TO TREAT TUMORS
#45Methods for treating cells containing fusion genes
#46Site-specific integration of transgenes
#47MONOCLONAL ANTI-TK1 ANTIBODIES
#48Transgenic macrophages, chimeric antigen receptors, and associated methods
#49SELECTIVE INSERTION OF SUICIDE GENES INTO CANCER CELLS
#50Thymidine kinase diagnostic assay for gene therapy applications
#51Thymidine kinase gene
#52ELIMINATION OF PROLIFERATING CELLS FROM STEM CELL-DERIVED GRAFTS
#53Combination Therapy For Cancer
#54CONDITIONAL RESCUE SYSTEM, CELLS, AND METHODS
#55Methods for treating cells containing fusion genes
#56Methods and Vectors to Produce Vector Free Induced Pluripotent Stem Cells
#57CONDITIONAL CYTOTOXIC GENE THERAPY VECTOR FOR SELECTABLE STEM CELL MODIFICATION FOR ANTI HIV GENE THERAPY
#58LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors
#59Macrophage CAR (MOTO-CAR) in immunotherapy
#60Cancer Therapy
#61Monoclonal anti-TK1 antibodies
#62TUMOR THERAPY WITH REPLICATION COMPETENT SINDBIS VIRAL VECTORS
#63Recombinant adenovirus with increased safety and anticancer activities, and use thereof
#64Replication competent pseudo-type retrovirus vector system
#65Matrix metalloproteinase cleavable protein polymers for cancer gene therapy
#66Methods of cytotoxic gene therapy to treat tumors
#67Compositions, methods and uses for treating solid tumors using LCMV-GP-VSV pseudotype vectors
#68Method for identifying and treating a patient having tumor lesions comprising administering a gene therapy retroviral vector particle comprising a mutated HSV-thymidine kinase (HSV-TK) polynucleotide
#69Thymidine kinase gene
#70Prodrug activation in cancer cells using molecular switches
#71Cancer therapy
#72NEURAL STEM CELL COMPOSITION CAPABLE OF TREATING CANCER AND METHOD OF TREATMENT
#73Treating Insulin Secreting Cells
#74LCMV-GP-VSV-pseudotyped vectors and tumor-infiltrating virus-producing cells for the therapy of tumors
#75Molecular Determinants Associated With Prostate Cancer And Methods Of Use Thereof
#76Prodrug activation in cancer cells using molecular switches
#77Tumor therapy with replication competent sindbis viral vectors
#78Treating hyperinsulinemia by killing beta cells with cytotoxic gene
#79Promoter driven tissue specific cytotoxic agents and title methods of use